Riskpilot← Back to searchSign inGet full accessKRAGERØ TABLETTPRODUKSJON DRIFT AS
ASActiveOrg 820229592Kirkegata 15, 3770 KragerøManufacture of pharmaceutical preparations · NACE 2120Est. 20185 employees
Revenue 2024
NOK 3M
+73% vs 2023
EBITDA margin
-26.1%
+32% vs 2023
Equity ratio
52.0%
Financial strength
Net profit 2024
NOK -766K
+33% vs 2023
| Revenue | NOK 3M | +73% |
| EBITDA | NOK -792K | +32% |
| Net profit | NOK -766K | +33% |
| Total assets | NOK 2,2M | +7% |
| Equity | NOK 1,1M | +0% |
| Employees | 5 | — |
Legal name
KRAGERØ TABLETTPRODUKSJON DRIFT AS
Org number
820229592
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
11. januar 2018
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Fabrikasjon av apotekrelaterte produkter samt bistand med driftsrelaterte oppgaver innen eget konsern.
Address
Kirkegata 15, 3770 Kragerø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1 500 | 1 750 | 1 800 | 900 | 900 | 1 750 | 3 030 |
| Staff expenses | −799 | −967 | −1 494 | −1 113 | −1 767 | −2 864 | −3 754 |
| EBITDA | 626 | 718 | 252 | −246 | −912 | −1 166 | −791 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 626 | 718 | 252 | −246 | −912 | −1 166 | −791 |
| Net financials | −93 | −77 | 10 | 5 | 5 | 16 | 25 |
| Profit before tax | 533 | 642 | 262 | −241 | −906 | −1 150 | −766 |
| Tax | 123 | 141 | 58 | −0 | −0 | −0 | −0 |
| Net profit | 410 | 500 | 204 | −241 | −906 | −1 150 | −766 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 2 787 | 1 315 | 1 510 | 1 610 | 1 720 | 2 064 | 2 200 |
| Equity | 440 | 941 | 1 145 | 1 145 | 1 145 | 1 145 | 1 145 |
| Long-term debt | 2 000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 347 | 375 | 365 | 466 | 575 | 919 | 1 055 |
| Total debt | 2 347 | 375 | 365 | 466 | 575 | 919 | 1 055 |
EBITDA margin
-26.1%
This company
15.8%
Market median
-265% vs market
20182024
Equity ratio
52.0%
This company
38.2%
Market median
+36% vs market
20182024
Return on equity
-66.9%
This company
18.4%
Market median
-464% vs market
20182024
Net profit margin
-25.3%
This company
8.1%
Market median
-412% vs market
20182024
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20182024
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RS Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Kragerø Tablettproduksjon As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pharmore As
KRAGERØ TABLETTPRODUKSJON DRIFT AS Board members of KRAGERØ TABLETTPRODUKSJON DRIFT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnar Salmen | Chief Executive Officer | 0 companies |